$DHC

Diversified Healthcare Trust 3Q 2026: Revenue $367.7M, EPS $(0.21) — 10-Q Summary

Diversified Healthcare Trust (DHC) reported 3Q 2026 revenue of $367.7M, down 5.4% YoY, and a net loss of $50.2M, or $(0.21) per share, improving from $(0.68) YoY. Senior-living revenue rose 5.8% with increased occupancy, while medical office and life science occupancy reached 88.4%. Seven skilled nursing facilities were leased to Ensign for $8M annually.

Original reporting
Published Nov 2, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Diversified Healthcare Trust 3Q 2026: Revenue $367.7M, EPS $(0.21) — 10-Q Summary — source image
Decision brief

The 30-second read

$DHCBullishMed
01

Why it matters

The earnings release provides fresh data on occupancy and lease activity that could influence valuation.

02

Market read

First‑hand earnings data for a REIT; may affect DHC price and sector sentiment.

03

What to watch

Potential impact of the new 15‑year triple‑net lease with Ensign on long‑term cash flow.

Relevance 7/10Novelty 7/10Timing: post-market release

Background

Diversified Healthcare Trust filed its 10‑Q for Q3 2026, reporting revenue and earnings details.

Company-level read

Ticker impact

$DHCBullishHigh confidence
Context

Q3 2026 earnings released showing revenue $367.7M and loss narrowing to $(0.21) per share.

Expected impact

likely upside as the market prices in the narrowed loss.

Evidence & confidence

Loss per share improved from $(0.68) to $(0.21) and occupancy trends are positive, suggesting better cash flow.

Market effects

Healthcare REITs may see modest support from improved occupancy trends.

U.S. REIT sector could experience slight positive bias.

Limited; primarily affects U.S. healthcare real estate investors.

Counterpoint

Despite loss narrowing, revenue decline and higher operating costs could pressure the stock.

Key entities

  • Diversified Healthcare Trust

    U.S. healthcare REIT (ticker DHC).

  • Ensign

    Entered a 15‑year triple‑net lease for seven skilled nursing facilities.

Related articles

$DHCMed

Diversified Healthcare Trust Announces Third Quarter 2026 Results

DIVERSIFIED HEALTHCARE TRUST (DHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Diversified Healthcare Trust Announces Third Quarter 2026 Results Provides Updated Full Year 2026 Financial Guidance Newton, MA (November 2, 2026): Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter

$DHCMed

Diversified Healthcare Trust Encounters Operational ‘Noise’ in Ongoing Portfolio Transitions

Diversified Healthcare Trust (Nasdaq: DHC) reported Q2 2026 average SHOP occupancy of 83.1%, up 70 bps sequentially and 160 bps year over year, but below expectations. Total revenue fell to $317.9 million from $327.5 million a year earlier. Same-property NOI margins rose to 17.3%. DHC reaffirmed 2026 SHOP NOI guidance but cut occupancy growth to 200 bps and revenue growth to about 6.6%, citing “transition noise” from 116 AlerisLife communities. Managed by RMR (Nasdaq: RMR).

$DHCMed

Diversified Healthcare Trust Announces Second Quarter 2026 Results

DIVERSIFIED HEALTHCARE TRUST (DHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Diversified Healthcare Trust Announces Second Quarter 2026 Results Provides Updated Full Year 2026 Financial Guidance Newton, MA (August 3, 2026): Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter e

$VVXHighAI 8/10

What V2X (VVX) Said on Its Q3 Earnings Call

V2X (VVX) reported Q3 revenue of $130M from national security activities, with full-year guidance raised. Asia-Pacific revenue grew 8% YoY, while Middle East revenue fell 30%. The company expects 2027 growth driven by Asia-Pacific demand and the T-6 program, despite Middle East challenges. Q3 operating cash flow was $61.8M, with net debt improving by $140.3M YoY.

$CLXMed

Clorox Q1 Earnings Call Highlights

Clorox (CLX) maintained its fiscal-year organic-sales-growth outlook of 3.5% to 4.5%, with Q2 expected to range from flat to down 2%. The company reported share gains in home care, Brita, and Hidden Valley Ranch, while Kingsford and cat litter faced challenges. Clorox is prioritizing pricing, innovation, and GOJO integration, with Fabian Garcia appointed as the next CEO. The company expects positive adjusted EPS impact from synergies in fiscal 2027.